D'ANNA, STEFANO
D'ANNA, STEFANO
Dipartimento di Biologia
Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort
2024-02-01 d'Arminio Monforte, A; Tavelli, A; Salpini, R; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Marchetti, Gc; Rosselli Del Turco, E; Rossotti, R; Mussini, C; Antinori, A; Lo Caputo, S; Ceccherini Silberstein, F; Gaeta, Gb; Svicher, V; Puoti, M
Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing
2023-01-01 Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F
Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; d’Arminio Monforte, A
Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage.
2023-01-01 Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R
Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V
Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks
2023-01-01 D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V
Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort
2023-09-01 Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M
PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150
2023-01-01 Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Gaeta, Gb; Marchetti, G; Rosselli Del Turco, E; Perno, Cf; Svicher, V; d'Arminio Monforte, A
Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication
2024-01-01 Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-feb-2024 | Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort | d'Arminio Monforte, A; Tavelli, A; Salpini, R; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Marchetti, Gc; Rosselli Del Turco, E; Rossotti, R; Mussini, C; Antinori, A; Lo Caputo, S; Ceccherini Silberstein, F; Gaeta, Gb; Svicher, V; Puoti, M | Articolo su rivista | |
| 1-gen-2023 | Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing | Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F | Articolo su rivista | |
| 1-gen-2023 | Hepatitis delta virus (HDV) infection : frequency and outcome in persons living with HIV (PLWH). Data from the ICONA (Italian cohort of naïve for antiretrovirals) cohort | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D’Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Battista Gaeta, G; Marchetti, G; Viale, P; Perno, C; Svicher, V; d’Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2023 | Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. | Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2023 | Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V | Intervento a convegno | |
| 1-gen-2023 | Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks | D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V | Intervento a convegno | |
| 1-set-2023 | Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort | Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M | Articolo su rivista | |
| 1-gen-2023 | PREVALENCE AND OUTCOME OF HEPATITIS DELTA VIRUS (HDV) INFECTION AMONG PERSONS LIVING WITH HIV (PLWH) IN ITALY: THE DELTA-ICONA STUDY OC 150 | Puoti, M; Salpini, R; Tavelli, A; Piermatteo, L; D'Anna, S; Carrara, S; Malagnino, V; Mazzotta, V; Brancaccio, G; Gaeta, Gb; Marchetti, G; Rosselli Del Turco, E; Perno, Cf; Svicher, V; d'Arminio Monforte, A | Intervento a convegno | |
| 1-gen-2024 | Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication | Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V | Articolo su rivista |